Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: An economic evaluation: Dedes KJ, Matter-Walstra K, Schwenkglenks M, et al (Univ Hosp of Zurich, Switzerland; Univ of Basel, Switzerland; et al) Eur J Cancer 45:1397-1406, 2009§